CFO4Life Group’s Vanguard FTSE Emerging Markets ETF VWO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.78M | Sell |
69,924
-537
| -0.8% | -$30.1K | 0.58% | 39 |
|
|
2025
Q4 | $3.79M | Sell |
70,461
-1,473
| -2% | -$80K | 0.54% | 39 |
|
|
2025
Q3 | $3.9M | Buy |
71,934
+1,130
| +2% | +$58.2K | 0.57% | 37 |
|
|
2025
Q2 | $3.5M | Sell |
70,804
-3,280
| -4% | -$152K | 0.55% | 37 |
|
|
2025
Q1 | $3.35M | Sell |
74,084
-193
| -0.3% | -$8.69K | 0.56% | 37 |
|
|
2024
Q4 | $3.27M | Buy |
74,277
+730
| +1% | +$33.9K | 0.57% | 33 |
|
|
2024
Q3 | $3.52M | Sell |
73,547
-187
| -0.3% | -$8.32K | 0.62% | 30 |
|
|
2024
Q2 | $3.23M | Sell |
73,734
-564,858
| -88% | -$24.3M | 0.61% | 30 |
|
|
2024
Q1 | $26.7M | Buy |
638,592
+291,267
| +84% | +$11.9M | 4.84% | 6 |
|
|
2023
Q4 | $14.3M | Sell |
347,325
-230,477
| -40% | -$9.14M | 2.73% | 11 |
|
|
2023
Q3 | $22.7M | Buy |
577,802
+29,546
| +5% | +$1.21M | 5.23% | 5 |
|
|
2023
Q2 | $22.3M | Buy |
548,256
+3,709
| +0.7% | +$150K | 4.79% | 7 |
|
|
2023
Q1 | $22M | Buy |
544,547
+321,802
| +144% | +$13.1M | 5% | 8 |
|
|
2022
Q4 | $8.68M | Sell |
222,745
-292,563
| -57% | -$11.2M | 1.85% | 13 |
|
|
2022
Q3 | $18.8M | Buy |
515,308
+26,085
| +5% | +$1.06M | 5% | 6 |
|
|
2022
Q2 | $19.7M | Buy |
489,223
+11,772
| +2% | +$508K | 4.89% | 6 |
|
|
2022
Q1 | $22M | Buy |
477,451
+445,894
| +1,413% | +$21.5M | 4.62% | 6 |
|
|
2021
Q4 | $1.56M | Buy |
31,557
+8,516
| +37% | +$429K | 0.32% | 43 |
|
|
2021
Q3 | $1.15M | Buy |
23,041
+4,624
| +25% | +$239K | 0.27% | 45 |
|
|
2021
Q2 | $1M | Buy |
18,417
+1,554
| +9% | +$82.8K | 0.23% | 52 |
|
|
2021
Q1 | $878K | Buy |
16,863
+3,687
| +28% | +$196K | 0.22% | 50 |
|
|
2020
Q4 | $660K | Buy |
13,176
+1,037
| +9% | +$48.7K | 0.19% | 61 |
|
|
2020
Q3 | $525K | Buy |
12,139
+440
| +4% | +$19.1K | 0.18% | 63 |
|
|
2020
Q2 | $463K | Buy |
11,699
+1,324
| +13% | +$49K | 0.18% | 61 |
|
|
2020
Q1 | $348K | Buy |
10,375
+5,644
| +119% | +$230K | 0.19% | 75 |
|
|
2019
Q4 | $210K | Buy |
+4,731
| New | +$200K | 0.09% | 118 |
|
|
2019
Q1 | – | Sell |
-6,592
| Closed | -$251K | – | 133 |
|
|
2018
Q4 | $251K | Sell |
6,592
-2,748
| -29% | -$106K | 0.11% | 95 |
|
|
2018
Q3 | $383K | Sell |
9,340
-3,618
| -28% | -$152K | 0.17% | 88 |
|
|
2018
Q2 | $547K | Hold |
12,958
| – | – | 0.23% | 66 |
|
|
2018
Q1 | $609K | Hold |
12,958
| – | – | 0.51% | 30 |
|
|
2017
Q4 | $595K | Hold |
12,958
| – | – | 0.47% | 36 |
|
|
2017
Q3 | $565K | Buy |
+12,958
| New | +$561K | 0.46% | 42 |
|
Other funds holding VWO
VGA
WL
CFO4Life Group's VWO Position: Q1 2026 in Review
CFO4Life Group reduced its Vanguard FTSE Emerging Markets ETF (VWO) stake by 0.76% in Q1 2026, selling an estimated $30.1K and leaving 69,924 shares worth $3.78M. The position accounts for 0.58% of the portfolio, ranked #39.
CFO4Life Group first reported a position in VWO in Q3 2017 and has held it in 32 quarters since. The position peaked at $26.7M in Q1 2024. 2,539 funds tracked by Wall St. Rank hold VWO as of Q1 2026.
- CFO4Life Group held 69,924 shares of Vanguard FTSE Emerging Markets ETF worth $3.78M as of Q1 2026.
- CFO4Life Group sold 537 Vanguard FTSE Emerging Markets ETF shares in Q1 2026, an estimated $30.1K.
- Vanguard FTSE Emerging Markets ETF made up 0.58% of CFO4Life Group's portfolio in Q1 2026, its #39 holding.
- CFO4Life Group first reported a position in Vanguard FTSE Emerging Markets ETF in Q3 2017 and has held it in 32 quarters since.
- CFO4Life Group's Vanguard FTSE Emerging Markets ETF position peaked at $26.7M in Q1 2024.
- 2,539 funds tracked by Wall St. Rank held Vanguard FTSE Emerging Markets ETF as of Q1 2026.
Based on CFO4Life Group's 13F filing for Q1 2026, filed 11 May 2026.